FindTrial
Sign In

Epidemiological open-label study to evaluate the frequency of helicobacter Pylori infections prior to and after equimolar switch from therapy with MMF to enteric-coated Mycophenolic Acid (MYFORTIC-ERL080) in stable renal transplant patients

Epidemiological open-label study to evaluate the frequency of helicobacter Pylori infections prior to and after equimolar switch from therapy with MMF to enteric-coated Mycophenolic Acid (MYFORTIC-ERL080) in stable renal transplant patients

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-002973-22-IT
Enrollment
250
Registered
2005-08-01
Start date
2004-04-28
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Profilaxis of rejection in stable renal transplant patients MedDRA version: 6.1 Level: PT Classification code 10046694

Interventions

Product Name: NA Product Code: NA Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Mycophenolic acid CAS Number: 115007-34-6 Current Sponsor code: ERL080 Other descriptive name: NA Concent

Sponsors

AZIENDA UNIVERSITARIA OSPEDALE POLICLINICO UMBERTO I
Lead Sponsor
AZIENDA POLICLINICO UMBERTO I
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026